Investing to become financially independent
Investing to become financially independent
Discover our detailed analysis of Sanofi Aventis, the world's 5th largest pharmaceutical group, and its attractiveness as a dividend stock. The stock, trading at attractive prices with a yield of 5.16% in 2011, has attractive characteristics despite its relative youth compared to other major players in the sector.
Sanofi Aventis (PA:SAN) Read More »
The portfolio suffered a drop in profitability to -4.74% following the fall of CenturyLink, but maintained a solid performance in euros with a Sharpe ratio higher than the benchmark indices. Dividends continue to rise, and new stocks such as Novartis and Roche are now being monitored to diversify the portfolio.
Released by CenturyLink... Read More »
The week saw a slight increase in our portfolio despite a slight fall in the US dollar, with our first 2011 dividend distribution from ABT. Although the euro had a turbulent week, our Sharpe ratio remains higher than that of the CAC 40 thanks to better profitability and lower volatility.
Français 
English 
Italiano 
Deutsch 
Español 
Português